Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial
Statistics in Medicine · 2025
DOI: 10.1002/sim.10345 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Fei Heng and 3 co-authors. Institution: Department of Mathematics and Statistics, University of North Florida, Jacksonville, Florida, USA. Major MEDLINE topics: COVID-19 Vaccines, COVID-19, SARS-CoV-2, Vaccine Efficacy. Cited 1 times so far (Crossref); 32 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIH HHS, National Science Foundation.
Abstract (original language)
Based on data from a randomized, controlled vaccine efficacy trial, this article develops statistical methods for assessing vaccine efficacy (VE) to prevent COVID‐19 infections by a discrete set of genetic strains of SARS‐CoV‐2. Strain‐specific VE adjusting for possibly time‐varying covariates is estimated using augmented inverse probability weighting to address missing viral genotypes under a competing risks model that allows separate baseline hazards for different risk groups. Hypothesis tests are developed to assess whether the vaccine provides at least a specified level of VE against some viral genotypes and whether VE varies across genotypes. Asymptotic properties providing analytic inferences are derived and finite‐sample properties of the estimators and hypothesis tests are studied through simulations. This research is motivated by the fact that previous analyses of COVID‐19 vaccine efficacy did not account for missing genotypes, which can cause severe bias and efficiency loss. The theoretical properties and simulations demonstrate superior performance of the new methods. Application to the Moderna COVE trial identifies several SARS‐CoV‐2 genotype features with differential vaccine efficacy across genotypes, including lineage (Reference, Epsilon, Gamma, Zeta), indicators of residue match vs. mismatch to the vaccine‐strain residue at Spike amino acid positions (identifying signatures of differential VE), and a weighted Hamming distance to the vaccine strain. The results show VE decreases against genotypes more distant from the vaccine strain, highlighting the need to update COVID‐19 vaccine strains.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Mathematics and Statistics, University of North Florida, Jacksonville, Florida, USA.
- Department of Mathematics and Statistics, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.
- Vaccine and Infectious Disease and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Department of Biostatistics, University of Washington, Seattle, Washington, USA.
ORCID profiles: Fei Heng
Funding
- NIAID NIH HHS
- NIH HHS
- National Science Foundation
- National Institutes of Health
Cite
APA
Heng, F., Sun, Y., Li, L., & B Gilbert, P. (2025). Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial. Statistics in Medicine. https://doi.org/10.1002/sim.10345
Vancouver
Heng F, Sun Y, Li L, B Gilbert P. Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial. Statistics in Medicine. 2025. doi:10.1002/sim.10345
BibTeX
@article{Heng2025,
author = {Heng, Fei and Sun, Yanqing and Li, Li and B Gilbert, Peter},
title = {Estimation and Hypothesis Testing of Strain‐Specific Vaccine Efficacy With Missing Strain Types With Application to a COVID‐19 Vaccine Trial},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.10345}
}
EUVIMED